Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Effect of Radix Astragali in combined therapy on T-lymphocyte subsets in patients with viral myocarditis

Abstract

The efficacy of Radix Astragali membranaceus (AM) oral liquor combined with routine therapy and routine therapy alone on T-lymphocyte subsets of peripheral blood in viral myocarditis patients have been studied comparatively. The results showed that the T-lymphocyte subsets profile and OKT4/OKT8 ratio of peripheral blood were significantly lower in viral myocarditis patients than that in healthy control (P < 0.05, 0.01). Routine therapy combined with AM could singificantly enhance OKT3, OKT4 and OKT4/OKT8 ratio in the above-mentioned patients (P <0.05, 0.01). The possible pharmacodynamic mechanism of combining routine therapy with AM in improving cell immunity in viral myocarditis patients was discussed.

This is a preview of subscription content, log in to check access.

Reference

  1. 1.

    l987; 26(10): 597.

  2. 2.

    HSU SM, Raine L. The use of acidin-biotin-peroxidase complex (ABC) in diagnostic and research pathology. In: Delellis RA, eds. Advances in immunohistochemistry. New York: Masson publishing USA, 1983:31–42.

  3. 3.

    1 1987:484.

  4. 4.

    1989; 5(2):58.

Download references

Author information

Correspondence to Zhao-Quan Huang or Nan-Ping Qin or Wu Ye or Ping Guo or Hui-Ren Wang.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Huang, Z., Qin, N., Ye, W. et al. Effect of Radix Astragali in combined therapy on T-lymphocyte subsets in patients with viral myocarditis. CJIM 2, 184–186 (1996). https://doi.org/10.1007/BF02934245

Download citation

Key Words

  • Radix Astragali
  • viral myocarditis
  • T-lymphocyte subsets